← Back to Search

Other

Percussive Therapy Device for Tennis Elbow

N/A
Waitlist Available
Led By Michael A Stone, M.D
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial tested a device that uses vibrations to treat acute tennis elbow, in addition to physical therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time to Improvement of Symptoms
Secondary outcome measures
PROMIS Depression
PROMIS Pain Interference
PROMIS Physical Functioning
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Percussive Therapy DeviceExperimental Treatment2 Interventions
Participants will be going to physical therapy - 1 session per week for 6 weeks and will use a percussive therapy device daily for 3-7 minutes
Group II: Control groupActive Control1 Intervention
Participants will be going to physical therapy - 1 session per week for 6 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Physical Therapy
2020
Completed Phase 4
~1460

Find a Location

Who is running the clinical trial?

Cedars-Sinai Medical CenterLead Sponsor
499 Previous Clinical Trials
164,791 Total Patients Enrolled
TherabodyUNKNOWN
Michael A Stone, M.DPrincipal InvestigatorCedars-Sinai Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings left for volunteers to participate in this trial?

"As indicated on clinicaltrials.gov, this research study is not currently open for enrolment. The trial was first published in March of 2023 and the latest changes were made in February of that same year. While it no longer enrolls patients, there are 22 other ongoing trials seeking participants presently."

Answered by AI
~32 spots leftby Apr 2025